abstract |
The invention relates to the technical field of medicaments, which discloses an application of Bortezomib in preparing drugs for curing POEMS syndrome and provides a drug capable of effectively curing POEMS syndrome, thus providing an effective, safe and novel curing approach for curing the POEMS syndrome, i.e. a proteasome inhibitor (Bortezomib) targeted therapy approach. |